1. Home
  2. WLDN vs FTRE Comparison

WLDN vs FTRE Comparison

Compare WLDN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willdan Group Inc.

WLDN

Willdan Group Inc.

HOLD

Current Price

$67.85

Market Cap

1.2B

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$20.37

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDN
FTRE
Founded
1964
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2006
2023

Fundamental Metrics

Financial Performance
Metric
WLDN
FTRE
Price
$67.85
$20.37
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$114.50
$14.06
AVG Volume (30 Days)
257.7K
1.2M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
120.89
N/A
EPS
0.55
N/A
Revenue
$273,352,000.00
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.05
$3.09
P/E Ratio
$127.55
N/A
Revenue Growth
N/A
1.00
52 Week Low
$64.67
$5.27
52 Week High
$137.00
$21.12

Technical Indicators

Market Signals
Indicator
WLDN
FTRE
Relative Strength Index (RSI) 28.21 76.09
Support Level $64.67 $9.10
Resistance Level $85.06 N/A
Average True Range (ATR) 2.73 0.85
MACD 0.08 0.21
Stochastic Oscillator 5.20 85.73

Price Performance

Historical Comparison
WLDN
FTRE

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: